Kyoto, Japan

Issei Akahoshi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Issei Akahoshi. Retrieved from https://idiyas.com/inventor/issei-akahoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Issei Akahoshi: Innovator in Medicinal Chemistry

Introduction

Issei Akahoshi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions that address pressing health issues.

Latest Patents

One of Akahoshi's notable patents is for a heteroaromatic amide derivative and medicament containing the same. This compound demonstrates high efficacy for diseases associated with Nav1.7 and is represented by a specific general formula. His patent portfolio includes 1 patent, showcasing his commitment to advancing medical science.

Career Highlights

Akahoshi is affiliated with Kaken Pharmaceutical Company, Ltd., where he applies his expertise in drug development. His role at the company allows him to collaborate with other talented professionals in the field. His contributions have been instrumental in the advancement of therapeutic options for patients.

Collaborations

Throughout his career, Akahoshi has worked alongside esteemed colleagues such as Yoshitake Sumikawa and Sadayoshi Furuta. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Issei Akahoshi's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His dedication to developing effective treatments continues to inspire advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…